Company ProfilePremium

LGC Biosearch Technologies (Douglas Scientific)

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
LGC Biosearch Technologies (Douglas Scientific) - Healthcare showcase

Year Founded & Workforce

1993

2,400 Employees

Industry

Healthcare

Services

PCR Kits and ReagentsRNA FISHCustom OligosInstruments and ConsumablesNGS Kits
L

LGC Biosearch Technologies (Douglas Scientific) Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

LGC Biosearch Technologies (Douglas Scientific) Overview

Company Headquarters: Petaluma, US

Founded: 1993

Workforce: ~2,400

Company Working:

LGC Biosearch Technologies operates as a subsidiary of LGC Limited and acquired Douglas Scientific in the year 2016. LGC, Biosearch Technologies designs, manufactures and markets PCR reagents, custom genotyping assays, genomic services, gene editing, and NGS services, as well as workflow solutions. The company operates in three business segments, namely, products, technologies, and services. It is present in more than 22 countries and has seven manufacturing units along with the three service laboratories all over the world. LGC Biosearch Technologies is a subsidiary of LGC Limited. Hence, the provided financial information is of LGC Limited.

Strategy

LGC Biosearch Technologies strongly emphasizes on strategic collaborations as well as mergers & acquisitions to enhance its product portfolio. For the success of these products, the company invests in sales and marketing. Moreover, it focuses on maximizing the growth of its core product segments by investing in R&D.

Company Snapshot

$18,274M

Revenue

2,400

Employees

1993

Founded

Petaluma, US

Headquarters

SWOT Analysis

Strengths

  • Diverse product portfolio
  • High investment in R&D
  • Strong presence in the Americas and Europe

Weaknesses

  • Limited presence in developing countries

Opportunities

  • Strategic collaborations and acquisitions to increase the product portfolio and global footprint

Threats

  • Tough competition from prominent market players

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • LGC Biosearch Technologies (Douglas Scientific)
    • PCR Kits and Reagents
    • RNA FISH
    • Custom Oligos
    • Instruments and Consumables
    • NGS Kits

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Total Revenue rose from USD 18,274 Mn in 2016 to USD 24,358 Mn in 2018.
LGC Biosearch Technologies (Douglas Scientific) — By Business Segment
Series (USD Mn)201620172018
Total Revenue18,27420,91824,358
R&D Expenses38.73031.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.